University of Iowa
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Iowa sits in the top decile of US sponsors by registered trial count (#143 of 15,742 sponsors by registered trial count).
University of Iowa: 228 sponsored US clinical trials, 28 recruiting.
University of Iowa sponsors 228 registered US clinical trials on ClinicalTrials.gov, 28 of them currently recruiting, and 156 completed. 23 of these trials are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 6 trials.
Top-decile sponsor footprint
University of Iowa ranks in the top decile of sponsors by registered trial count (#143 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
156 of 184 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
228 total, page 4 of 5
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
NCT01406860
Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer
NCT01419483
Development and Validation of a Disability Severity Index for CMT
NCT01455623
A Randomized Controlled Trial to Improve Teen Driving
NCT01624597
Efficacy of Yoga for Postpartum Depression
NCT02213601
Pediatric Radial Arterial Cannulation
NCT01276158
Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity
NCT01351753
Combined Illness Management and Psychotherapy in Treating Depressed Elders
NCT01337726
Low Intensity Resistance Training With Partial Blood Flow Restriction for Quadriceps Strengthening
NCT01311206
Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients
NCT01170247
Platform Exercise Training
NCT01239823
A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department
NCT01749605
Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)
NCT01381354
Personal Health Records and Elder Medication Use Quality
NCT02012712
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
NCT01203085
Ultrasound-image Guided Versus Doppler Guided Versus Palpation Technique for Arterial Cannulation in Adults
NCT01276171
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
NCT00935077
Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat
NCT00925132
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck
NCT01065844
FLT PET Imaging for Cervical Cancer
NCT01075412
The Effect of Low-Level Laser Stimulation on Hearing Thresholds
NCT01820416
A Study to Test Lung Function After Radiation Therapy
NCT01039649
Xylitol Versus Saline in Chronic Sinusitis
NCT00924404
Aquatic Power Training
NCT00904319
The Effectiveness of Smoking Cessation Guidelines in the Emergency Department
NCT00756704
Mobility Optimization Through Velocity Exercise
NCT00844558
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer
NCT00791336
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
NCT00721799
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases
NCT00513903
Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients
NCT01002118
Zinc to Treat Tinnitus in the Elderly
NCT00683644
Motivational Interviewing Intervention for Intimate Partner Violence
NCT01410669
Improving Walking in Older Adults With Knee Osteoarthritis
NCT00583245
Effectiveness of Hearing-aid Based Wind-noise Algorithm
NCT00738244
Evaluation of the Bausch & Lomb PureVision Under Nighttime Driving Conditions
NCT00581659
Celecoxib as a Post-tonsillectomy Pain Medication
NCT00583453
Yoga to Reduce Cancer Fatigue
NCT00583739
Efficacy and Safety of Omalizumab in Bullous Pemphigoid
NCT00472030
Central Venous Pressure (CVP) Assessment by Ultrasound and Physical Examination
NCT01099241
Internal Jugular Vein Cross Sectional Area
NCT01099254
Parent-based Intervention to Increase Safe Teen Driving
NCT01014923
Human Lung Responses to Respiratory Pathogens
NCT01967628
Extending Acute Stroke Trials to the Aerial Inter-hospital Transfer Setting
NCT00585351
Effect of Exercise on Endothelial Function and Vascular Compliance in Chronic Kidney Disease
NCT01068314
TENS Effectiveness and Knee Osteoarthritis in Humans
NCT01354054
Oral Cleft Prevention Program
NCT00397917
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
NCT00426127
Interpersonal Psychotherapy for Depression in People With Heart Failure
NCT00353223
Ultrasound Targeting for the Lumpectomy Cavity
NCT00583843
Behavioral Intervention and Adherence in Dialysis
NCT01066949
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 22 |
| Phase 2 | 27 |
| Phase 3 | 4 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Iowa pipeline
28 recruiting of 228 indexed (12% open); 156 completed (68%).
Phase mix: 23 late (III/IV) vs 49 early (I/II) (early-phase heavy).
Top condition: Healthy (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Iowa: open-pipeline peers nationwide
Peers matched on 228 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
University of Iowa sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 228 trials (± recruiting share)
- Georgetown University · 227 trials · 15% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
- Brown University · 231 trials · 15% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Daiichi Sankyo · 12% recruiting · 236 trials
- Augusta University · 12% recruiting · 106 trials
- National Institute of Mental Health (NIMH) · 12% recruiting · 343 trials
- Friends Research Institute · 12% recruiting · 41 trials
Related
What to do with this University of Iowa page
228 registered trials is a research-attention snapshot, not an endorsement of University of Iowa or any single study.
- 28 of University of Iowa's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Iowa studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Iowa pipeline card: 228 registered trials from official public datasets.Report a data error.